Conference Reports

These consist of reports on key commissioning conferences, meetings or symposia.

The Editorial Advisory Board invites readers to send in reports from any relevant meetings for publication.

Recent Conference Reports include

» Commissioning cancer care: report from the 2011 London Cancer New Drugs Group annual conference

» Improving access to new cancer medicines: report from the 2010 LCNDG annual conference

» New cancer medicines: Joint working between the NHS and the pharmaceutical industry

» Cancer Commissioning—at a global and a local level: London Cancer New Drugs Group Annual Meeting

» Commissioning Cancer Drugs and Services. The London Cancer New Drugs Group Meeting

» The London Cancer New Drugs Group Meeting 2008

Commissioning Cancer Drugs and Services

0 comment on this article - Be the first to comment

To say that the imposing façade of RIBA headquarters instilled in arriving delegates a sense of trepidation would be pure conjecture; that the conference to which they were arriving would ask more questions than it answered, however, must have been forecast by all 200 who attended.

Convened by the London Cancer New Drugs Group (LCNDG) to discuss the commissioning of cancer drugs and services, the aims of the conference were three-fold:

To explore how cancer drugs and supportive care could be effectively commissioned alongside cancer services and within the context of the wider commissioning agenda
To discuss environmental changes that might alter the role of health technology assessment
To facilitate an understanding of the work of the LCNDG and other health technology appraisal (HTA) bodies amongst stakeholders, including commissioners and the pharmaceutical industry

Read Full Article

Page 2 of 2 pages
< 1 2